Parallel imports play a central role when it comes to ensuring access to affordable medicines and promoting competition in the pharmaceutical market.
The term 'parallel import' describes the legal import of medicines from one country to another, independent of the consent of the original manufacturer or rights holder. This is the case when, for example, identical or similar medicines are available at a lower price in another country. Parallel imports are an important tool for offering medicines at lower prices. This stimulates competition in the market.
The relevance of parallel imports lies above all in the economic benefit for patients and healthcare systems. By sourcing affordable medicines, the overall burden on the healthcare system can be reduced. Especially for essential medicines, this can be crucial, as lower prices enable broader access for more people.
Furthermore, parallel imports increase patient choice. Competition between different providers ensures that patients have access to a wider range of medicines at different prices. This gives them the freedom to choose the most suitable and affordable treatment option for them.
However, it is important to emphasize that the parallel import of medicines is subject to strict legal and regulatory requirements. Importing companies must ensure that the imported medicines meet the quality and safety standards of the destination country. This is usually ensured through extensive testing procedures and controls to guarantee the quality and efficacy of the imported medicines compared to the original products.
However, parallel imports also bring challenges. Some manufacturers and rights holders may restrict the import of their products to other countries or hinder the supply and availability of parallel imports. In addition, there may be differences in packaging and labeling, as the imported medicines come from different countries. This requires careful monitoring and regulation to ensure the quality and safety of the imported medicines.
In summary, the parallel import of medicines plays an important role in ensuring access to affordable medicines and promoting competition in the pharmaceutical market. It enables patients to have a greater choice of treatment options and can help reduce overall healthcare costs. Strict legal and regulatory requirements ensure that imported medicines meet quality and safety standards.
If you have further questions or would like more detailed information on the topic of parallel import, we are happy to help you.
In the field of clinical research, two identification numbers play a central role: the EudraCT number and the NCT number.
Comparator products are essential in clinical trials for assessing the efficacy and safety of new medicines.
Certificates of Analysis (CoA), Certificates of Origin (CoO), and Certificates of Conformity (CoC) play an important role in ensuring quality, origin, and conformity.
Parallel imports play a central role in ensuring access to affordable medicines and promoting competition in the market.
